In the highly regulated and competitive world of clinical research, one often overlooked factor can make or break a trial’s outcome: study startup efficiency. From the moment a protocol is finalized to the activation of the first clinical site, every day counts. Delays in the startup phase ripple through recruitment, data collection, timelines, and ultimately the drug development path....